Jae Park

Jae Park, MD, Memorial Sloan Kettering Cancer Center, explains CAR T-cell therapy, which is currently being investigated in patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia, and non-Hodgkin lymphoma.